Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure

Exposure to high altitudes generates a decrease in the partial pressure of oxygen, triggering a hypobaric hypoxic condition. This condition produces pathophysiologic alterations in an organism. In the lung, one of the principal responses to hypoxia is the development of hypoxic pulmonary vasoconstri...

Full description

Bibliographic Details
Main Authors: Samia El Alam, Eduardo Pena, Diego Aguilera, Patricia Siques, Julio Brito
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/20/12656
_version_ 1797472675065495552
author Samia El Alam
Eduardo Pena
Diego Aguilera
Patricia Siques
Julio Brito
author_facet Samia El Alam
Eduardo Pena
Diego Aguilera
Patricia Siques
Julio Brito
author_sort Samia El Alam
collection DOAJ
description Exposure to high altitudes generates a decrease in the partial pressure of oxygen, triggering a hypobaric hypoxic condition. This condition produces pathophysiologic alterations in an organism. In the lung, one of the principal responses to hypoxia is the development of hypoxic pulmonary vasoconstriction (HPV), which improves gas exchange. However, when HPV is exacerbated, it induces high-altitude pulmonary hypertension (HAPH). Another important illness in hypobaric hypoxia is high-altitude pulmonary edema (HAPE), which occurs under acute exposure. Several studies have shown that inflammatory processes are activated in high-altitude illnesses, highlighting the importance of the crosstalk between hypoxia and inflammation. The aim of this review is to determine the inflammatory pathways involved in hypobaric hypoxia, to investigate the key role of inflammation in lung pathologies, such as HAPH and HAPE, and to summarize different anti-inflammatory treatment approaches for these high-altitude illnesses. In conclusion, both HAPE and HAPH show an increase in inflammatory cell infiltration (macrophages and neutrophils), cytokine levels (IL-6, TNF-α and IL-1β), chemokine levels (MCP-1), and cell adhesion molecule levels (ICAM-1 and VCAM-1), and anti-inflammatory treatments (decreasing all inflammatory components mentioned above) seem to be promising mitigation strategies for treating lung pathologies associated with high-altitude exposure.
first_indexed 2024-03-09T20:04:41Z
format Article
id doaj.art-4be51221495148dfbb8900b5de4390b7
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T20:04:41Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-4be51221495148dfbb8900b5de4390b72023-11-24T00:34:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-10-0123201265610.3390/ijms232012656Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia ExposureSamia El Alam0Eduardo Pena1Diego Aguilera2Patricia Siques3Julio Brito4Institute of Health Studies, Arturo Prat University, Iquique 1100000, ChileInstitute of Health Studies, Arturo Prat University, Iquique 1100000, ChileInstitute of Health Studies, Arturo Prat University, Iquique 1100000, ChileInstitute of Health Studies, Arturo Prat University, Iquique 1100000, ChileInstitute of Health Studies, Arturo Prat University, Iquique 1100000, ChileExposure to high altitudes generates a decrease in the partial pressure of oxygen, triggering a hypobaric hypoxic condition. This condition produces pathophysiologic alterations in an organism. In the lung, one of the principal responses to hypoxia is the development of hypoxic pulmonary vasoconstriction (HPV), which improves gas exchange. However, when HPV is exacerbated, it induces high-altitude pulmonary hypertension (HAPH). Another important illness in hypobaric hypoxia is high-altitude pulmonary edema (HAPE), which occurs under acute exposure. Several studies have shown that inflammatory processes are activated in high-altitude illnesses, highlighting the importance of the crosstalk between hypoxia and inflammation. The aim of this review is to determine the inflammatory pathways involved in hypobaric hypoxia, to investigate the key role of inflammation in lung pathologies, such as HAPH and HAPE, and to summarize different anti-inflammatory treatment approaches for these high-altitude illnesses. In conclusion, both HAPE and HAPH show an increase in inflammatory cell infiltration (macrophages and neutrophils), cytokine levels (IL-6, TNF-α and IL-1β), chemokine levels (MCP-1), and cell adhesion molecule levels (ICAM-1 and VCAM-1), and anti-inflammatory treatments (decreasing all inflammatory components mentioned above) seem to be promising mitigation strategies for treating lung pathologies associated with high-altitude exposure.https://www.mdpi.com/1422-0067/23/20/12656inflammationhigh altitudepulmonary edemapulmonary hypertensionhypoxia
spellingShingle Samia El Alam
Eduardo Pena
Diego Aguilera
Patricia Siques
Julio Brito
Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
International Journal of Molecular Sciences
inflammation
high altitude
pulmonary edema
pulmonary hypertension
hypoxia
title Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
title_full Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
title_fullStr Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
title_full_unstemmed Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
title_short Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure
title_sort inflammation in pulmonary hypertension and edema induced by hypobaric hypoxia exposure
topic inflammation
high altitude
pulmonary edema
pulmonary hypertension
hypoxia
url https://www.mdpi.com/1422-0067/23/20/12656
work_keys_str_mv AT samiaelalam inflammationinpulmonaryhypertensionandedemainducedbyhypobarichypoxiaexposure
AT eduardopena inflammationinpulmonaryhypertensionandedemainducedbyhypobarichypoxiaexposure
AT diegoaguilera inflammationinpulmonaryhypertensionandedemainducedbyhypobarichypoxiaexposure
AT patriciasiques inflammationinpulmonaryhypertensionandedemainducedbyhypobarichypoxiaexposure
AT juliobrito inflammationinpulmonaryhypertensionandedemainducedbyhypobarichypoxiaexposure